The toxic side effects of an experimental cancer drug from Onyx Pharmaceuticals may outweigh its benefits for patients with a type of blood cancer, federal health regulators said Monday.
Related posts:
Antarctic ice shelves not melting at all, new field data show
Spaceman-Turned-Politician Can Call Himself 'Astronaut' on Ballot
Easy, natural ways to reduce skin cancer risk
Twitter Literature [COMIC]
Stuart Shaw of Castle Broughton died warning motorists of black ice after being hit by car
Part 4: Mysterious 12,000-Years-Old Gobekli Tepe, Turkey